Table of Content

1 Study Coverage
1.1 Viral Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Viral Vaccines Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global Viral Vaccines Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global Viral Vaccines Market by Region
1.4.1 Global Viral Vaccines Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global Viral Vaccines Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Viral Vaccines Revenue by Players
2.1.1 Global Viral Vaccines Revenue by Players (2019-2024)
2.1.2 Global Viral Vaccines Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by Viral Vaccines Revenue in 2024
2.2 Global Viral Vaccines Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Viral Vaccines Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Merck & Co., Inc.
3.1.1 Merck & Co., Inc. Information
3.1.2 Merck & Co., Inc. Overview
3.1.3 Merck & Co., Inc. Viral Vaccines Revenue and Gross Margin (2019-2024)
3.1.4 Merck & Co., Inc. Related Developments
3.2 Novartis, Inc.
3.2.1 Novartis, Inc. Information
3.2.2 Novartis, Inc. Overview
3.2.3 Novartis, Inc. Viral Vaccines Revenue and Gross Margin (2019-2024)
3.2.4 Novartis, Inc. Related Developments
3.3 Emergent BioSolutions Inc.
3.3.1 Emergent BioSolutions Inc. Information
3.3.2 Emergent BioSolutions Inc. Overview
3.3.3 Emergent BioSolutions Inc. Viral Vaccines Revenue and Gross Margin (2019-2024)
3.3.4 Emergent BioSolutions Inc. Related Developments
3.4 GlaxoSmithKline plc
3.4.1 GlaxoSmithKline plc Information
3.4.2 GlaxoSmithKline plc Overview
3.4.3 GlaxoSmithKline plc Viral Vaccines Revenue and Gross Margin (2019-2024)
3.4.4 GlaxoSmithKline plc Related Developments
3.5 Serum institute of India Private Limited
3.5.1 Serum institute of India Private Limited Information
3.5.2 Serum institute of India Private Limited Overview
3.5.3 Serum institute of India Private Limited Viral Vaccines Revenue and Gross Margin (2019-2024)
3.5.4 Serum institute of India Private Limited Related Developments
3.6 Seqirus (CSL Limited)
3.6.1 Seqirus (CSL Limited) Information
3.6.2 Seqirus (CSL Limited) Overview
3.6.3 Seqirus (CSL Limited) Viral Vaccines Revenue and Gross Margin (2019-2024)
3.6.4 Seqirus (CSL Limited) Related Developments
3.7 Pfizer, Inc.
3.7.1 Pfizer, Inc. Information
3.7.2 Pfizer, Inc. Overview
3.7.3 Pfizer, Inc. Viral Vaccines Revenue and Gross Margin (2019-2024)
3.7.4 Pfizer, Inc. Related Developments
3.8 Sanofi
3.8.1 Sanofi Information
3.8.2 Sanofi Overview
3.8.3 Sanofi Viral Vaccines Revenue and Gross Margin (2019-2024)
3.8.4 Sanofi Related Developments
3.9 AstraZeneca plc
3.9.1 AstraZeneca plc Information
3.9.2 AstraZeneca plc Overview
3.9.3 AstraZeneca plc Viral Vaccines Revenue and Gross Margin (2019-2024)
3.9.4 AstraZeneca plc Related Developments
3.10 Novavax, Inc.
3.10.1 Novavax, Inc. Information
3.10.2 Novavax, Inc. Overview
3.10.3 Novavax, Inc. Viral Vaccines Revenue and Gross Margin (2019-2024)
3.10.4 Novavax, Inc. Related Developments
4 Global Viral Vaccines Market Insights
4.1 Global Viral Vaccines Market Revenue 2019-2024
4.2 Global Viral Vaccines Revenue by Region
4.3 Americas
4.4 Europe
4.5 Asia-Pacific
4.6 Middle East & Africa
5 Market Size by Type
5.1 Global Viral Vaccines Revenue by Type
5.2 Global Viral Vaccines Market Size Growth by Type 2019-2024
6 Market Size by Application
6.1 Global Viral Vaccines Revenue by Application
6.2 Global Viral Vaccines Market Size Growth by Application 2019-2024
7 Americas
7.1 Americas Viral Vaccines Market Size by Type
7.1.1 Americas Viral Vaccines Revenue by Type (2019-2024)
7.1.2 Americas Viral Vaccines Revenue Share by Type (2019-2024)
7.2 Americas Viral Vaccines Market Size by Application
7.2.1 Americas Viral Vaccines Revenue by Application (2019-2024)
7.2.2 Americas Viral Vaccines Revenue Share by Application (2019-2024)
7.3 Americas Viral Vaccines Market Size by Country
7.3.1 Americas Viral Vaccines Revenue by Country (2019-2024)
7.3.2 U.S.
7.3.3 Canada
7.3.4 Mexico
7.3.5 Brazil
7.3.6 Argentina
8 Europe
8.1 Europe Viral Vaccines Market Size by Type
8.1.1 Europe Viral Vaccines Revenue by Type (2019-2024)
8.1.2 Europe Viral Vaccines Revenue Share by Type (2019-2024)
8.2 Europe Viral Vaccines Market Size by Application
8.2.1 Europe Viral Vaccines Revenue by Application (2019-2024)
8.2.2 Europe Viral Vaccines Revenue Share by Application (2019-2024)
8.3 Europe Viral Vaccines Market Size by Country
8.3.1 Europe Viral Vaccines Revenue by Country (2019-2024)
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
9 Asia Pacific
9.1 Asia Pacific Viral Vaccines Market Size by Type
9.1.1 Asia Pacific Viral Vaccines Revenue by Type (2019-2024)
9.1.2 Asia Pacific Viral Vaccines Revenue Share by Type (2019-2024)
9.2 Asia Pacific Viral Vaccines Market Size by Application
9.2.1 Asia Pacific Viral Vaccines Revenue by Application (2019-2024)
9.2.2 Asia Pacific Viral Vaccines Revenue Share by Application (2019-2024)
9.3 Asia Pacific Viral Vaccines Market Size by Region
9.3.1 Asia Pacific Viral Vaccines Revenue by Region (2019-2024)
9.3.2 China
9.3.3 Japan
9.3.4 South Korea
9.3.5 India
9.3.6 Southeast Asia
9.3.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Viral Vaccines Market Size by Type
10.1.1 Middle East and Africa Viral Vaccines Revenue by Type (2019-2024)
10.1.2 Middle East and Africa Viral Vaccines Revenue Share by Type (2019-2024)
10.2 Middle East and Africa Viral Vaccines Market Size by Application
10.2.1 Middle East and Africa Viral Vaccines Revenue by Application (2019-2024)
10.2.2 Middle East and Africa Viral Vaccines Revenue Share by Application (2019-2024)
10.3 Middle East and Africa Viral Vaccines Market Size by Country
10.3.1 Middle East and Africa Viral Vaccines Revenue by Country (2019-2024)
10.3.2 Turkey
10.3.3 Saudi Arabia
10.3.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Viral Vaccines Industry Trends
11.2 Viral Vaccines Market Drivers
11.3 Viral Vaccines Market Challenges
11.4 Viral Vaccines Market Restraints
12 Viral Vaccines Forecasted Market Size by Type
12.1 Global Viral Vaccines Forecasted Revenue by Type
12.2 Global Viral Vaccines Forecasted Market Size Growth by Type 2024-2030
13 Viral Vaccines Forecasted Market Size by Application
13.1 Global Viral Vaccines Forecasted Revenue by Application
13.2 Global Viral Vaccines Forecasted Market Size Growth by Application 2024-2030
14 Global Viral Vaccines Market Forecasts
14.1 Global Viral Vaccines Market Revenue Forecasts 2024-2030
14.2 Global Viral Vaccines Forecasts Revenue by Region
14.3 Americas
14.4 Europe
14.5 Asia-Pacific
14.6 Middle East & Africa
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer